Early events of HIV infection as targets for antiviral agents.
Datema
R
R
Virology Department 106, Bristol-Myers Squibb Company, Wallingford, Connecticut 06492.
D000998:Antiviral Agents / Q000494:pharmacology*; D015704:CD4 Antigens / Q000276:immunology; D015699:HIV Envelope Protein gp120 / Q000276:immunology; D015700:HIV Envelope Protein gp41 / Q000276:immunology; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D015728:Receptors, HIV / Q000187:drug effects / Q000378:metabolism
D000998:Antiviral Agents; D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D015700:HIV Envelope Protein gp41; D015728:Receptors, HIV